The US Food and Drug Administration (FDA) recently issued a warning letter to TEI Biosciences, a unit of Integra LifeSciences, for releasing collagen-based products which failed bacterial endotoxin ...
Oncology drug and biologics developers received new guidance on setting limits for endotoxins during the clinical trial process, in the form of a draft document from the US Food and Drug ...
Supply disruptions of neurosurgical patties, sponges and strip devices could affect patient care and neurosurgical procedures through the end of 2026, according to a May 6 letter by the FDA. The ...
AGAWAM, Mass., Oct. 24, 2012 /PRNewswire/ -- A new white paper is available to assist medical device manufacturers with understanding recent changes to the U.S. Food and Drug Administration's (FDA) ...
Despite taking the dramatic step earlier this year of voluntarily recalling a broad swath of its regenerative tissue technologies and pausing further production at its Boston-based manufacturing ...
If you more than glance at the website for NuVision Pharmacy, you might start having second thoughts about having the Dallas-based company compound your pharmaceuticals. Why, you might wonder by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results